Core Viewpoint - H&H International Holdings reported a 12.0% year-on-year increase in total revenue for the nine months ending September 30, 2025, driven by strong growth in its infant nutrition and care products segment, particularly in infant formula milk powder [1] Group 1: Financial Performance - Total revenue reached RMB 10.805 billion, with a 12.3% increase on a like-for-like basis [1] - The infant nutrition and care products segment experienced a significant growth rate of 24.0%, primarily due to a 33.3% year-on-year increase in infant formula milk powder sales [1] - The infant probiotics and nutritional supplements segment saw a reduced decline of 2.3%, with a strong double-digit growth resurgence in the last three months of the reporting period [1] Group 2: Market Outlook - According to Founder Securities, the infant formula milk powder industry is currently under pressure due to demand factors, but H&H's sales in this category increased by 10.0% year-on-year in the first half of 2025, outperforming the industry average [1] - The strong sales performance of Stage 1 and Stage 2 infant formula milk powder is a key driver of this growth [1] - The ongoing implementation of childcare subsidy policies is expected to improve demand for infant formula milk powder, with H&H's products likely to maintain a growth trajectory, while the infant probiotics and nutritional supplements are anticipated to gradually return to a growth path [1]

Core Insights - H&H International Holdings (01112) reported a 12.0% year-on-year increase in total revenue for the nine months ending September 30, 2025, reaching RMB 10.805 billion, with a 12.3% increase on a like-for-like basis [1] Revenue Breakdown - All business segments recorded positive growth, with the high-margin nutritional supplements accounting for 64.5% of total revenue [1] - The vitamins, herbal and mineral supplements, and pet nutrition categories achieved revenue growth of 6.0% and 14.2% on a like-for-like basis, respectively [1] Segment Performance - The adult nutrition and care products segment grew by 5.2% on a reported basis and 6.0% on a like-for-like basis, driven by strong double-digit growth in mainland China and expanding markets [1] - The infant nutrition and care products segment accelerated its growth, with a 24.0% increase, primarily due to a 33.3% year-on-year growth in infant formula milk powder [1] - The infant probiotics and nutritional supplements business saw a reduced decline of 2.3%, with a return to strong double-digit growth in the last three months of the reporting period [1]

Core Insights - H&H International Holdings (01112) reported a 12.0% year-on-year increase in total revenue for the nine months ending September 30, 2025, reaching RMB 10.805 billion [1] - All business segments experienced positive growth, with the high-margin nutritional supplements accounting for 64.5% of total revenue [1] - The adult nutrition and care products segment grew by 5.2% year-on-year, driven by strong double-digit growth in mainland China and expanding markets [1] - The infant nutrition and care products segment accelerated its growth to 24.0%, primarily due to a 33.3% year-on-year increase in infant formula milk powder sales [1] - The infant probiotics and nutritional supplements business saw a reduced decline of 2.3%, with a return to strong double-digit growth in the last three months of the reporting period [1]

Core Insights - H&H International Holdings reported a mid-single-digit revenue growth for the six months ending June 30, 2025, driven by growth across all business segments, including adult nutrition and care products, infant nutrition and care products, and pet nutrition and care products [1] Group 1: Adult Nutrition and Care Products - The adult nutrition and care products segment experienced a mid-single-digit revenue increase, primarily due to double-digit growth in mainland China and strong performance in other expanding markets [1] - The growth in this segment is attributed to rising consumer demand for beauty, anti-aging, and detox products, as well as the success of innovative product lines such as Swisse Plus+, Little Swisse, Smart Melts, and Swisse Magnesium Glycinate [1] - Swisse maintains a leading position in the overall vitamin, herbal, and mineral supplement market in mainland China, benefiting from its strong e-commerce presence [1] Group 2: Infant Nutrition and Care Products - The infant nutrition and care products segment saw a return to growth with a low single-digit year-on-year increase, driven by high single-digit growth in infant formula sales [2] - The strategy to attract new consumers, particularly through e-commerce and specialty infant stores, has helped expand market share, with Biostime's ultra-premium infant formula market share increasing from 13.0% to 15.8% [2] - During the 618 online shopping festival, the sales volume of the first and second stages of infant formula recorded a 103% increase [2] - However, the infant probiotics and nutritional supplements segment experienced a double-digit year-on-year decline due to reduced foot traffic in pharmacy channels and industry-wide challenges, although online sales in mainland China still showed low single-digit growth [2] Group 3: Pet Nutrition and Care Products - The pet nutrition and care products segment recorded a high single-digit revenue growth compared to the same period last year, benefiting from the increasing trend of premiumization in pet nutrition, pet humanization, and a rising number of pets [3] - The high-margin pet supplements segment continues to achieve steady revenue growth in the low to mid-double digits [3]